What percentage of hyaluronic acid actually works?

With actives like niacinamide or vitamin C, percentage maps to a meaningful dose-response curve: more delivers stronger effect up to a ceiling. Hyaluronic acid does not work that way. It is a humectant, not a pharmacologically active small molecule competing for a receptor or enzyme. Its job is to bind and hold water in the stratum corneum — and it does that job at concentrations as low as 0.1%. The Pavicic et al. 2011 RCT (n=76 women, 60 days) tested five molecular weights of sodium hyaluronate all formulated at 0.1% and all produced statistically significant improvements in skin hydration and overall elasticity versus placebo. Products go up to approximately 2% — the concentration range the CIR Expert Panel assessed as safe — but formulators cap there because higher concentrations produce thick, tacky textures, not because higher concentrations deliver more. Chasing a product with '2% hyaluronic acid' over one with '0.1%' is optimizing for marketing copy, not efficacy.

• Study 0.1% sodium hyaluronate formulations across all five molecular weights (50-2000 kDa) demonstrated significant skin hydration and elasticity improvements in a 60-day RCT (n=76 women). ¹
• CIR Hyaluronic acid and its salts are used in cosmetics at concentrations up to 2%; the CIR Expert Panel found these concentrations safe for use in present practices. ²

High-MW hyaluronic acid (>1000 kDa) cannot penetrate the intact stratum corneum — the molecules are simply too large. Raman spectroscopy of human skin ex vivo confirmed that 1000–1400 kDa HA remains entirely at the surface. This is not a flaw; it is a mechanism. On the surface, high-MW HA forms a thin, viscoelastic film that limits transepidermal water loss (TEWL), provides an immediate tactile plumping effect, and interacts with CD44 receptors to exert anti-inflammatory signaling. In the comparative crosslinked HA study (PMID:27050698), high-MW linear HA reduced TEWL by 15.6% versus baseline in a dynamic human explant model. The surface film makes high-MW HA particularly well suited to dry or barrier-compromised skin where reducing water escape matters most.

• Study Hyaluronic acid of 1000-1400 kDa molecular weight does not penetrate through the stratum corneum, as demonstrated by Raman micro-imaging of human skin ex vivo; low-MW HA (20-300 kDa) crossed the stratum corneum. ³
• Review High molecular weight HA functions through CD44 receptor interaction to inhibit inflammatory cytokine production, reduce macrophage phagocytosis, and act as anti-inflammatory in contrast to pro-inflammatory low-MW fragments. ⁴
• Study Topical crosslinked resilient hyaluronic acid (RHA) reduced TEWL by 27.8% versus -15.6% for high-MW linear HA and +55.5% (increase) for low-MW linear HA in a dynamic 3D human explant model. ⁵

Low-MW and hydrolyzed hyaluronic acid (20–300 kDa) penetrates the stratum corneum and reaches the superficial epidermis, enabling humectancy at a deeper level than the surface film. The same Raman spectroscopy study that confirmed high-MW impermeability also demonstrated that 20–300 kDa HA crosses the stratum corneum. In the Pavicic et al. 2011 multi-weight RCT, the lowest molecular weights (50 and 130 kDa) produced the greatest reduction in wrinkle depth among all five weights tested — consistent with deeper penetration contributing incrementally to anti-wrinkle effects. However, lower MW forms provide less TEWL reduction than high-MW. A notable finding from the crosslinked HA pilot study (PMID:27050698) is that low-MW linear HA actually increased TEWL by 55.5% versus baseline in the ex vivo model — a reminder that penetrating more is not always better for barrier function. There is also a theoretical biological caveat: very small HA oligomers (<10 kDa) act as damage-associated molecular patterns (DAMPs) and can activate pro-inflammatory TLR2/TLR4 signaling. The clinical relevance for cosmetically applied low-MW HA at 0.1–2% has not been established in human RCTs, but it is a known biological complexity worth naming.

• Study Low molecular weight HA (20-300 kDa) penetrates through the stratum corneum while high MW HA (1000-1400 kDa) remains impermeant, as shown by Raman spectroscopy in human skin ex vivo. ³
• Study Topical 0.1% hyaluronic acid formulations across five molecular weights (50, 130, 300, 800, and 2000 kDa) all produced significant improvement in skin hydration and overall elasticity versus placebo after 60 days, with lower molecular weights (50 and 130 kDa) showing greater reduction in wrinkle depth. ¹
• Review Low MW HA fragments act as DAMPs, promoting dendritic cell activation and maturation and release of pro-inflammatory cytokines (IL-1β, TNF-α) via TLR2/TLR4 signaling, in contrast to the anti-inflammatory signaling of intact high-MW HA via CD44. ⁴
• Study Topical crosslinked resilient hyaluronic acid (RHA) reduced TEWL by 27.8% versus -15.6% for high-MW linear HA and +55.5% (increase) for low-MW linear HA in a dynamic 3D human explant model. ⁵

Products marketing 'multiple weights of hyaluronic acid' are addressing a real mechanism gap, not just inflating ingredient lists. A formulation combining high-MW HA (surface film, TEWL reduction, anti-inflammatory signaling) with low-MW HA (deeper epidermal humectancy, potentially better wrinkle depth reduction) captures both mechanisms. A 30-day double-blind, placebo-controlled RCT (n=40) testing a product containing six types of hyaluronic acid showed lip volume increase of 14.2%, wrinkle volume decrease of 26.3%, and wrinkle depth reduction of 21.8% versus placebo. Nano-hyaluronic acid particles (~5 nm), the smallest commercial form, applied twice daily for 8 weeks improved skin hydration by up to 96%, reduced wrinkle depth by up to 40%, and improved elastic recovery by up to 55% in a single-arm clinical study, though without a randomized control group that finding requires independent replication. The weight blend itself, not the total HA percentage, drives these effects.

• Study A double-blind, placebo-controlled RCT (n=40) of a topical product containing six types of hyaluronic acid showed lip volume increase of 14.2%, wrinkle volume decrease of 26.3%, and wrinkle depth reduction of 21.8% after 30 days versus placebo. ⁶
• Study Nano-hyaluronic acid particles (~5 nm) applied twice daily for 8 weeks significantly improved skin hydration by up to 96%, reduced wrinkle depth by up to 40%, and improved elastic recovery by up to 55% in a single-arm clinical study. ⁸

Hyaluronic acid is a humectant — it draws water from wherever water is most available. In humid environments (above roughly 70% relative humidity), that water comes from the air, and HA does its job well. In dry or cold air, the gradient reverses: HA draws water upward from the deeper epidermis and dermis. That water then evaporates from the skin surface without an occlusive barrier to trap it, and net skin dryness results. This is not a speculation — the mechanism is well-established humectant behavior, and the TEWL data from PMID:27050698 showed that low-MW linear HA increased TEWL by 55.5% versus baseline in an ex vivo model under conditions that favored surface evaporation. The fix is straightforward: apply HA to damp skin or in a humid environment, then immediately layer an occlusive or emollient on top to trap the drawn water. Standalone HA serum worn without any sealing moisturizer in a dry heated apartment is a setup for the humectant backfire — the percentage on the label is irrelevant to that outcome.

• Study Topical crosslinked resilient hyaluronic acid (RHA) reduced TEWL by 27.8% versus -15.6% for high-MW linear HA and +55.5% (increase) for low-MW linear HA in a dynamic 3D human explant model. ⁵
• Review HA is a hygroscopic molecule that can bind 1,000 times its volume in water, functioning as a potent humectant in the stratum corneum and superficial epidermis. ⁹

One honest caveat A dedicated RCT measuring HA-specific TEWL increase under controlled low-humidity human exposure has not been published. The humectant draw-out mechanism is well established for humectants as a class; the TEWL data from PMID:27050698 are from an ex vivo dynamic explant model, not a live-skin RCT in controlled-humidity conditions.

Setting aside molecular weight nuance, what does topical HA reliably do in human RCTs? At 0.1% across all molecular weights (50–2000 kDa): significant improvement in skin hydration and overall elasticity in a 60-day placebo-controlled RCT (Pavicic 2011, n=76). With a six-type HA blend: significant lip volume, wrinkle volume, and wrinkle depth improvements in 30 days versus placebo (Nobile 2014, n=40). In a 24-week combination study using a topical HA-filler serum alongside botulinum toxin: statistically significant improvements of approximately 14–24% in fine lines, crow's feet, skin tone, texture, radiance, and elasticity versus control (Bravo 2022). The short answer: topical HA measurably improves hydration and fine lines caused by dryness. Claims that it 'fills' or 'replenishes' the dermis are not supported — topical HA does not reach the dermis at any molecular weight, and even low-MW forms penetrate only to the superficial epidermis.

• Study Topical 0.1% hyaluronic acid formulations across five molecular weights (50, 130, 300, 800, and 2000 kDa) all produced significant improvement in skin hydration and overall elasticity versus placebo after 60 days, with lower molecular weights (50 and 130 kDa) showing greater reduction in wrinkle depth. ¹
• Study A double-blind, placebo-controlled RCT (n=40) of a topical product containing six types of hyaluronic acid showed lip volume increase of 14.2%, wrinkle volume decrease of 26.3%, and wrinkle depth reduction of 21.8% after 30 days versus placebo. ⁶
• Study A 24-week randomized controlled trial combining a topical HA-filler serum with botulinum toxin type A demonstrated statistically significant improvements in fine lines, crow's feet wrinkles, skin tone, texture, radiance, and elasticity of approximately 14-24% versus the control group. ⁷
• Study Low molecular weight HA (20-300 kDa) penetrates through the stratum corneum while high MW HA (1000-1400 kDa) remains impermeant, as shown by Raman spectroscopy in human skin ex vivo. ³

What percentage of hyaluronic acid is best?

The question itself is misleading for HA. Significant skin hydration and elasticity improvements are documented at 0.1% across all molecular weights in a 60-day RCT (Pavicic 2011, PMID:22052267). Products go up to 2% — the safe-use ceiling per CIR (PMID:19636067) — but there is no evidence that 2% outperforms 0.1% on skin benefit. The real variable is molecular weight, not concentration. ¹²

High vs low molecular weight hyaluronic acid — which is better?

Neither is universally superior; they work differently. High-MW HA (>1000 kDa) stays on the surface, forms a TEWL-reducing film, and has anti-inflammatory CD44 signaling. Low-MW HA (<300 kDa) penetrates the stratum corneum and in the Pavicic 2011 RCT (PMID:22052267), the lowest MW forms (50 and 130 kDa) reduced wrinkle depth most. However, low-MW linear HA increased TEWL by 55.5% in a dynamic explant model (PMID:27050698) — deeper penetration is not always better for barrier function. There is also a theoretical DAMP/pro-inflammatory signal from very small HA oligomers (<10 kDa) via TLR2/TLR4 (PMID:35369538), though clinical significance in topical cosmetic use has not been established. Multi-weight blends combine both mechanisms. ¹³⁵⁴

Can hyaluronic acid dry out your skin?

Yes, in dry or cold environments. Humectants draw water from wherever water is most available — in low-humidity air, that means pulling from the deeper epidermis and dermis rather than from the atmosphere. In a dynamic 3D human explant model, low-MW linear HA increased TEWL by 55.5% versus baseline (PMID:27050698), confirming the mechanism operates. The fix: apply HA to damp skin, then immediately seal with an occlusive or emollient to trap the drawn water. This is a formulation and application problem, not a percentage problem. ⁵⁹

Does hyaluronic acid actually penetrate skin?

Partially, depending on molecular weight. Raman spectroscopy of human skin ex vivo (Essendoubi et al., PMID:25877232) confirmed that high-MW HA (1000–1400 kDa) does not cross the intact stratum corneum; low-MW HA (20–300 kDa) does cross. Neither reaches the dermis. Marketing claims that topical HA 'replenishes' the dermis or 'penetrates deeply' are not supported by current penetration data. ³¹⁰

What is the difference between hyaluronic acid and sodium hyaluronate?

Sodium hyaluronate is the sodium salt of hyaluronic acid. At equivalent molecular weight they have the same biological activity. Sodium hyaluronate is more stable in formulation and is the predominant commercial form. Critically, the INCI name 'Sodium Hyaluronate' on an ingredient list tells you nothing about molecular weight — it could be high, low, or hydrolyzed. The salt vs. free acid distinction is a formulation chemistry matter, not a consumer-facing benefit distinction. ²⁹

1. 1

   Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment

   Pavicic T, Gauglitz GG, Lersch P, Schwach-Abdellaoui K, Malle B, Korting HC, Farwick M · Journal of Drugs in Dermatology 10(9):990-1000 · 2011

2. 2

   Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate

   Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW; Cosmetic Ingredient Review Expert Panel; Andersen FA · International Journal of Toxicology 28(4 Suppl):5-67 · 2009

3. 3

   Human skin penetration of hyaluronic acid of different molecular weights as probed by Raman spectroscopy

   Essendoubi M, Gobinet C, Reynaud R, Angiboust JF, Manfait M, Piot O · Skin Research and Technology 22(1):55-62 · 2016

4. 4

   Action of Hyaluronic Acid as a Damage-Associated Molecular Pattern Molecule and Its Function on the Treatment of Temporomandibular Disorders

   Ferreira NDR, Sanz CK, Raybolt A, Pereira CM, DosSantos MF · Frontiers in Pain Research (Lausanne) 3:852249 · 2022

5. 5

   Pilot Comparative Study of the Topical Action of a Novel, Crosslinked Resilient Hyaluronic Acid on Skin Hydration and Barrier Function in a Dynamic, Three-Dimensional Human Explant Model

   Sundaram H, Mackiewicz N, Burton E, Peno-Mazzarino L, Lati E, Meunier S · Journal of Drugs in Dermatology 15(4):434-41 · 2016

6. 6

   Anti-aging and filling efficacy of six types hyaluronic acid based dermo-cosmetic treatment: double blind, randomized clinical trial of efficacy and safety

   Nobile V, Buonocore D, Michelotti A, Marzatico F · Journal of Cosmetic Dermatology 13(4):277-87 · 2014

7. 7

   Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence

   Bravo B, Correia P, Gonçalves Junior JE, Sant'Anna B, Kerob D · Dermatologic Therapy 35(12):e15903 · 2022

8. 8

   Efficacy of a New Topical Nano-hyaluronic Acid in Humans

   Jegasothy SM, Zabolotniaia V, Bielfeldt S · The Journal of Clinical and Aesthetic Dermatology 7(3):27-29 · 2014

9. 9

   Hyaluronic acid, a promising skin rejuvenating biomedicine: A review of recent updates and pre-clinical and clinical investigations on cosmetic and nutricosmetic effects

   Bukhari SNA, Roswandi NL, Waqas M, Habib H, Hussain F, Khan S, Sohail M, Ramli NA, Thu HE, Hussain Z · International Journal of Biological Macromolecules 120(Pt B):1682-1695 · 2018

10. 10

    Interactions of hyaluronic Acid with the skin and implications for the dermal delivery of biomacromolecules

    Witting M, Boreham A, Brodwolf R, Vávrová K, Alexiev U, Friess W, Hedtrich S · Molecular Pharmaceutics 12(5):1391-401 · 2015